Title : Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.

Pub. Date : 2022 Mar 1

PMID : 35233056






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens